ARVN
ARVINAS, INC. · Healthcare · Market cap $533.6M
Insiders sold $518K net in the last 90 days ·5 sellers, 0 buyers· latest Form 4 filed Jun 24, 2026
Insider Buying
$495K
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Jun 26, 2026
Saik Andrew
ARVINAS, INC. (ARVN) has 33 SEC Form 4 filings (37 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jun 26, 2026.
Inside the rolling window, 7 insiders at ARVINAS, INC. reported 2 open-market purchases totaling $495K and 19 open-market sales totaling $1.4M. The most active filer is Chief Scientific Officer Cacace Angela M with 4 filings. Insiders have net sold $1.2M over the trailing 6 months. The most recent open-market filing is a sale of 5,696 shares by Chief Financial Officer Saik Andrew, dated Jun 24, 2026, worth $46K.
- Industry:Biotechnology
- CEO:Randy Teel
- Employees:246
- HQ:New Haven, CT, US
- IPO:2018-09-27
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | Sale | 5,696 | $46K | Jun 24 | +1.4% | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,576 | $20K | Jun 18 | +6.4% | SEC ↗ | |
| President and CEO | Sale | 2,209 | $20K | May 22 | -10.2% | SEC ↗ | |
| President and CEO | Sale | 9,657 | $96K | May 13 | -17.3% | SEC ↗ | |
| Chief Scientific Officer | Sale | 9,657 | $96K | May 13 | -17.3% | SEC ↗ | |
| Chief Financial Officer | Sale | 11,139 | $111K | May 13 | -17.3% | SEC ↗ | |
| VP, Chief Accounting Officer | Sale | 1,919 | $19K | May 13 | -17.3% | SEC ↗ | |
| Chief Medical Officer | Sale | 11,108 | $110K | May 13 | -17.3% | SEC ↗ | |
| Chief Medical Officer | Sale | 6,435 | $71K | Mar 19 | -26.9% | SEC ↗ | |
Morrison BriggsFirst in 6 months | Director | Purchase | 20,000 | $268K | Mar 9 | -39.0% | SEC ↗ |
Houston John GFirst filing | Director | Sale | 35,297 | $466K | Mar 2 | — | SEC ↗ |
| Chief Scientific Officer | Sale | 3,609 | $44K | Feb 25 | — | SEC ↗ | |
| President and CEO | Sale | 4,786 | $58K | Feb 25 | — | SEC ↗ | |
| Chief Accounting Officer | Sale | 1,108 | $13K | Feb 25 | — | SEC ↗ | |
Cacace Angela MFirst filing | Chief Scientific Officer | Sale | 4,592 | $55K | Feb 18 | — | SEC ↗ |
Saik AndrewFirst filing | Chief Financial Officer | Sale | 5,134 | $61K | Feb 18 | — | SEC ↗ |
Teel RandyFirst filing | President and CEO | Sale | 4,403 | $52K | Feb 18 | — | SEC ↗ |
Loomis David KFirst in 3 months | Chief Accounting Officer | Sale | 1,016 | $12K | Feb 18 | — | SEC ↗ |
Berkowitz NoahFirst filing | Chief Medical Officer | Sale | 5,685 | $68K | Feb 18 | — | SEC ↗ |
Loomis David KFirst filing | Chief Accounting Officer | Sale | 230 | $2K | Nov 7 | — | SEC ↗ |
Morrison BriggsFirst filing | Director | Purchase | 30,000 | $227K | Sep 24 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ARVN have?
ARVINAS, INC. (ARVN) has 33 SEC Form 4 filings (37 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Jun 26, 2026.
When was the most recent SEC Form 4 filing for ARVN?
The most recent Form 4 filing for ARVN on Tracefour is dated Jun 26, 2026.
Who is the most active insider at ARVN?
The most active SEC Form 4 filer at ARVN in the rolling window is Chief Scientific Officer Cacace Angela M, with 4 filings.
What is the net insider flow at ARVN over the last 6 months?
Over the trailing 180 days, insiders at ARVN have net sold $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ARVN in the current window?
Inside the rolling window, insiders at ARVN bought $495K and sold $1.4M based on SEC Form 4 filings.
Can I get alerts for ARVN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ARVINAS, INC. (ARVN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ARVINAS, INC. is in the Healthcare sector.